Hanmi Pharm. (KRX:128940) posted a 115% year-over-year surge in attributable net income for the second quarter to 83.3 billion won from 38.7 billion won.
Sales surged 29% to 467.2 billion won for the three months ended June 30 from 361.3 billion won, based on a bourse filing on Tuesday.